Completed NA INTERVENTIONAL 2-arm NCT05484102

Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children (FERCT19)

Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Upper Respiratory Tract and Gastrointestinal Infectious Diseases in Children: a Double-blind, Randomized, Placebo-controlled Trial

Sponsor: Heinz Italia SpA

Conditions Children, Only Gastrointestinal Infection Upper Respiratory Tract Infections

Interventions milk fermented with lactobacillus paracasei CBA L74 placebo milk formula

Updated 5 times since 2022 Last updated: Sep 17, 2024 Started: Sep 15, 2022 Primary completion: Jan 10, 2024 Completion: Jan 11, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Children, Only and Gastrointestinal Infection and is currently completed. Heinz Italia SpA leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Oct 2024 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2024 — Oct 2024 [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heinz Italia SpA
University of Bari

Data source: University of Bari

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bari, Italy